<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AComparable_company_analysis</id>
	<title>Definition:Comparable company analysis - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AComparable_company_analysis"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Comparable_company_analysis&amp;action=history"/>
	<updated>2026-05-02T14:56:16Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Comparable_company_analysis&amp;diff=20350&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Comparable_company_analysis&amp;diff=20350&amp;oldid=prev"/>
		<updated>2026-03-17T16:04:46Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;📈 &amp;#039;&amp;#039;&amp;#039;Comparable company analysis&amp;#039;&amp;#039;&amp;#039; is a [[Definition:Valuation | valuation]] methodology widely used in insurance [[Definition:Mergers and acquisitions (M&amp;amp;A) | M&amp;amp;A]], [[Definition:Equity research | equity research]], and [[Definition:Initial public offering (IPO) | IPO]] pricing that estimates the value of an insurance company by benchmarking it against publicly traded peers with similar business characteristics. Often called &amp;quot;trading comps&amp;quot; or &amp;quot;peer analysis,&amp;quot; the approach relies on the principle that companies operating in comparable [[Definition:Line of business | lines of business]], geographies, and risk profiles should trade at broadly similar multiples of key financial metrics. In insurance, the relevant multiples differ from those used in many other industries: [[Definition:Price-to-book ratio | price-to-book value]] (P/BV), [[Definition:Price-to-earnings ratio | price-to-earnings]] (P/E), and price-to-[[Definition:Tangible book value | tangible book value]] are the workhorses, supplemented by metrics such as price-to-[[Definition:Embedded value | embedded value]] for [[Definition:Life insurance | life insurers]] and multiples of [[Definition:Gross written premium | gross written premium]] for high-growth or distribution-oriented businesses like [[Definition:Managing general agent (MGA) | MGAs]].&lt;br /&gt;
&lt;br /&gt;
⚙️ Constructing a meaningful comparable set in insurance requires careful attention to business mix, risk profile, and accounting framework. A [[Definition:Specialty insurance | specialty]] [[Definition:Excess and surplus lines insurance | E&amp;amp;S]] carrier should not be compared uncritically to a large multiline personal-lines writer, even if both are classified as property-casualty insurers, because their growth rates, [[Definition:Combined ratio | combined ratios]], [[Definition:Return on equity (ROE) | return on equity]], and capital intensity differ fundamentally. Geographic and regulatory context also matters: a European insurer reporting under [[Definition:IFRS 17 | IFRS 17]] may present different earnings patterns than a U.S. peer reporting under [[Definition:US GAAP | US GAAP]], making direct multiple comparisons less straightforward without adjustments. Analysts typically compile a peer universe, calculate the relevant multiples for each company, derive a central tendency (median or mean), and then apply those multiples to the target company&amp;#039;s financials — often with premiums or discounts to reflect qualitative differences such as franchise value, management quality, or [[Definition:Underwriting | underwriting]] track record. For [[Definition:Reinsurance | reinsurers]], Bermuda-domiciled specialists, and [[Definition:Lloyd&amp;#039;s of London | Lloyd&amp;#039;s]] vehicles, dedicated peer groups have developed over time, each with its own valuation conventions.&lt;br /&gt;
&lt;br /&gt;
🎯 The practical value of comparable company analysis lies in its market-grounded objectivity — it anchors valuation in what investors are actually willing to pay for similar businesses, rather than relying solely on intrinsic [[Definition:Discounted cash flow (DCF) | discounted cash flow]] models that depend on long-range assumptions about loss development and investment returns. In insurance M&amp;amp;A transactions, investment banks routinely present comps alongside [[Definition:Precedent transaction analysis | precedent transaction analysis]] and actuarial appraisal values to triangulate a fair price range. The method is equally important for [[Definition:Insurtech | insurtech]] companies seeking public listings, where the choice between insurance-sector comps and technology-sector comps can dramatically influence perceived valuation. Despite its usefulness, the approach has limitations: insurance companies are rarely perfect comparables, and periods of market dislocation — such as post-catastrophe [[Definition:Hard market | hard markets]] or financial crises — can distort multiples in ways that obscure fundamental value.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Precedent transaction analysis]]&lt;br /&gt;
* [[Definition:Embedded value]]&lt;br /&gt;
* [[Definition:Price-to-book ratio]]&lt;br /&gt;
* [[Definition:Discounted cash flow (DCF)]]&lt;br /&gt;
* [[Definition:Return on equity (ROE)]]&lt;br /&gt;
* [[Definition:Mergers and acquisitions (M&amp;amp;A)]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>